Restorsea Rejuvenating Day Spf 30 Broad Spectrum Uva Uvb With Vibransea Complex Lotion
NDC Package 57670-000-00
Package Information
Restorsea Rejuvenating Day Spf 30 Broad Spectrum Uva Uvb With Vibransea Complex (zinc oxide) lotions is a medication used to treat and prevent diaper rash and other minor skin irritations (e.g., burns, cuts, scrapes). This formulation utilizes a lotion delivery system. Marketed by Restorsea Inc, this product is identified by NDC 57670-000 and is authorized under FDA application M020.
Identification & Billing
- RxCUI: 244637 - zinc oxide 20 % Topical Lotion
- RxCUI: 244637 - zinc oxide 200 MG/ML Topical Lotion
- RxCUI: 244637 - ZnO 20 % Topical Lotion
- RxCUI: 244637 - ZNO 200 MG/ML Topical Lotion
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 57670 - Restorsea Inc
- 57670-000 - Restorsea Rejuvenating Day Spf 30 Broad Spectrum Uva Uvb With Vibransea Complex
- 57670-000-00 - 1 TUBE in 1 CARTON / 50 g in 1 TUBE
- 57670-000 - Restorsea Rejuvenating Day Spf 30 Broad Spectrum Uva Uvb With Vibransea Complex
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 57670-000-00 identifies a specific commercial package of 1 tube in 1 carton / 50 g in 1 tube of Restorsea Rejuvenating Day Spf 30 Broad Spectrum Uva Uvb With Vibransea Complex, a human over the counter drug labeled by Restorsea Inc. This lotion is formulated for topical use and contains zinc oxide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Restorsea Inc on December 24, 2012. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used to treat and prevent diaper rash and other minor skin irritations (e.g., burns, cuts, scrapes). It works by forming a barrier on the skin to protect it from irritants/moisture.
How is this Restorsea Inc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 57670000000. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.